Journals / İstanbul Üniversitesi İstanbul Tıp Fakültesi Mecmuası / 2002 / Cilt: 65 - Sayı: 1

An autoimmune cholangitis case

Bir otoimmün kolanjit vakası

Pages
53–56
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Because it is a newly defined and rare disease, we present a case that was admitted to, and whose diagnosis was confirmed in our clinic.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Autoimmune cholangitis is a chronic inflammatory liver disease characterized by cholestatic and hepatocellular findings.
📊
Key Findings & Data:Most of affected patients are middle age women and present with itching, fatigue, arthralgia and jaundice.
💡
Conclusion & Impact:Because it is a newly defined and rare disease, we present a case that was admitted to, and whose diagnosis was confirmed in our clinic.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Autoimmune cholangitis is a chronic inflammatory liver disease characterized by cholestatic and hepatocellular findings. Most of affected patients are middle age women and present with itching, fatigue, arthralgia and jaundice. The disease resembles primary biliary cirrhosis histologically, however distinction between the diseases is made by positive antinuclear antibody and/or antismooth muscle antibody, and negative antimitochondrial antibody titers. Eliminating other causes of liver damage confirms the diagnosis. Management includes use of immunosuppresive agents and ursodeoxycholic acid. Its prognosis is poorer than that of biliary cirrhosis. Because it is a newly defined and rare disease, we present a case that was admitted to, and whose diagnosis was confirmed in our clinic.

Özet

Otoimmun kolanjit kolestatik ve hepatoselüler özelliklere sahip kronik inflamatuar bir karaciğer hastalığıdır. Hastalar çoğunlukla orta yaşlı kadınlardır ve kaşıntı, yorgunluk, artralji, sarılık yakınması ile başvururlar. Histolojik olarak primer biliyer siroz ile benzerlik gösteren bu hastalık, esasen antinükleer antikor ve/veya antidüz kas antikor pozitifliği, antimitokondriyal antikor negatifliği ile ondan ayrılan bir antitedir. Karaciğer hasarına ait diğer etiyolojik nedenlerin dışlanması ile tanı kesinleştirilir. Tedavide immunsüpressif ajanlar ve ursodeoksikolik asid kullanılmaktadır. Prognozu primer biliyer siroza göre daha kötüdür. Yeni tanımlanan ve nadir görülen bir hastalık olması nedeni ile kliniğimizde yatırılarak tanısı kesinleştirilen bir olgu burada sunulmuştur.

🔖

Cite This Article

ÇEVİKBAŞ, U., YILMAZ, A., BEŞIŞIK, F., ÖKTEN, A., ÇAKALOĞLU, Y., GÜLŞEN, M., KARACA, Ç. (2022). An autoimmune cholangitis case. İstanbul Üniversitesi İstanbul Tıp Fakültesi Mecmuası, Cilt: 65 - Sayı: 1, 53–56. https://ajindex.com/articles/553732

References (6)

  1. Albert J. Czaja, Herschel A Carpenter, Paula j. Santrach. et al: Autoimmune cholangitis within the spectrum of autoimmune liver disease. Hepatology 31:1231 (2000)
  2. John M. Vierling: Clinics in liver disease, Autoimmun cholangiopathy, North America Series, Los Angeles, (1999), Sf.:571
  3. Kawaguchi N, Miyakawa H, Abe K. et al: Western blot analysis of anti-M2 antibodies in anti-mitochondrial antibody-negative primary biliary cirrhosis. Rinsho Byori 11:1079 (1997)
  4. Kinoshita H, Omagari K, Whittingham S. et al: Autoimmune cholangitis and primary biliary cirrhosis an autoimmune enigma. Liver 2:122 (1999)
  5. Masumoto T, Ninomiya T, Michitaka K. et al: Three patients with autoimmune cholangiopathy treated with prednisolone. J Gastroenterol 6:909 (1998)
  6. Sherlock DS. Autoimmune cholangitis: a unique entity? Mayo Clin Proc 73:184 (1998).